Trial intelligence / Profile preview

Steroid protocol development after cataract surgery

RBR-2frpntvPhase 4Not yet recruiting

Sponsor
Instituto para o Desenvolvimento da Educação
Start
Dec 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexamethasone, prednisolone and loteprednol etabonate in cataract (4 arms), sponsored by Instituto para o Desenvolvimento da Educação. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

dexamethasoneprednisoloneloteprednol etabonate
03

Conditions

cataract

Beyond the preview

Go deeper on RBR-2frpntv.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-2frpntv.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call